- Home
- AUPH vs DRD Comparison
AUPH vs DRD Comparison
Compare AUPH & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- DRD
- Stock Information
- Founded
- AUPH 1993
- DRD 1895
- Country
- AUPH Canada
- DRD South Africa
- Employees
- AUPH N/A
- DRD 2956
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- DRD Precious Metals
- Sector
- AUPH Health Care
- DRD Basic Materials
- Exchange
- AUPH Nasdaq
- DRD Nasdaq
- Market Cap
- AUPH 1.3B
- DRD 743.5M
- IPO Year
- AUPH 1999
- DRD N/A
- Fundamental
- Price
- AUPH $8.98
- DRD $8.91
- Analyst Decision
- AUPH Strong Buy
- DRD Strong Buy
- Analyst Count
- AUPH 3
- DRD 1
- Target Price
- AUPH $10.33
- DRD $13.25
- AVG Volume (30 Days)
- AUPH 1.4M
- DRD 208.3K
- Earning Date
- AUPH 02-13-2025
- DRD 01-01-0001
- Dividend Yield
- AUPH N/A
- DRD 2.54%
- EPS Growth
- AUPH N/A
- DRD 3.58
- EPS
- AUPH N/A
- DRD 0.84
- Revenue
- AUPH $220,361,000.00
- DRD $341,805,849.00
- Revenue This Year
- AUPH $36.97
- DRD $20.95
- Revenue Next Year
- AUPH $16.43
- DRD N/A
- P/E Ratio
- AUPH N/A
- DRD $10.26
- Revenue Growth
- AUPH 38.72
- DRD 13.53
- 52 Week Low
- AUPH $4.71
- DRD $6.48
- 52 Week High
- AUPH $10.67
- DRD $12.70
- Technical
- Relative Strength Index (RSI)
- AUPH 51.68
- DRD 42.01
- Support Level
- AUPH $8.91
- DRD $8.38
- Resistance Level
- AUPH $9.31
- DRD $10.20
- Average True Range (ATR)
- AUPH 0.32
- DRD 0.28
- MACD
- AUPH -0.09
- DRD 0.01
- Stochastic Oscillator
- AUPH 14.29
- DRD 32.03
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About DRD DRDGOLD Limited
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.